Synergy CHC Corp. Common Stock (SNYR) — Analysis Summary
Synergy CHC Corp. Common Stock (SNYR) has a market cap of $1.56M with year-over-year revenue growth of -12.8%. Net margin stands at -40.6%. The stock trades at a P/E ratio of -0.1.
Key Takeaways
- Revenue changed -12.8% year-over-year
- Net margin of -40.6%
- P/E ratio of -0.1
Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, SNYR posted revenue growth of -12.8% and trades at a P/E of -0.1.
Synergy CHC Corp. Common Stock (SNYR)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -1.5x — earnings do not cover interest payments
Shareholder equity is negative, which can signal balance-sheet stress.
Current ratio at 0.93x — current liabilities exceed current assets
Operating margin at -39.6% — material operating losses
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer-branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen, amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Employees
28
Headquarters
WESTBROOK, ME
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.